Clinical trial

Predictives Factors of Cardiac Resynchronization Therapy: a Multimodal Analysis Using 2D Speckle Tracking Echocardiography Coupled With MIBG Myocardial Scintigraphy and Heart Failure Biomarkers

NCT02018029

StatusUNKNOWN

Study typeOBSERVATIONAL

Start date2013-03-01

PhaseN/A

Study timeline

Study start (unknown)2013-03-01Date precision: month

Registry last updated2013-12-23

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Heart Failureunresolved

Reduced Ejection Fractionunresolved

Interventions

cardiac resynchronisation therapyOTHER

Sponsors & collaborators

University Hospital, Clermont-Ferrandlead sponsor

General Electrics Francecollaborator

Mapped research locations

Clermont-FerrandFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02018029 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.